Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients (Q73411365)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165401%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165401%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165401%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

J L Pujol

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165401%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J Grenier

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165401%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

X Quantin

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165401%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 February 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165401%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

number of pages

11

1 reference

inferred from page(s)

published in

Lung Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165401%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165401%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165401%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

221-231

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165401%20AND%20SRC:MED&resulttype=core&format=json

Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working Party

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

Prognostic value of histology in patients with non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

Conditional survival among patients with carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

Analysis of early and late deaths on RTOG non-small cell carcinoma of the lung trials: comparison with CALGB 8433.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Correlation with TNM stage and disease free and overall survival

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

CEA, CYFRA21-1 and SCC in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

Cytokeratins as serum markers in lung cancer: a comparison of CYFRA 21-1 and TPS

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

Diagnostic and prognostic value of Cyfra 21-1 compared with other tumour markers in patients with non-small cell lung cancer: a prospective study of 116 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

Preoperative CYFRA 21-1 level as a prognostic indicator in resected nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma: does the combined use of cytokeratin markers give any additional information?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

The clinical value of Cyfra 21-1 estimation for lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

Neuron specific enolase, carcinoembryonic antigen and lactate dehydrogenase as indicators of disease activity in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

Value of serum neuron-specific enolase in nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

The World Health Organization histological typing of lung tumours. Second edition

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

A computer program for non-parametric receiver operating characteristic analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

The clinical behavior of "mixed" small cell/large cell bronchogenic carcinoma compared to "pure" small cell subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

Neural cell adhesion molecule and prognosis of surgically resected lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

Klaas Breur Medal lecture 1985. The growth and progression of human tumors: implications for management strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900186-0

7 January 2021

10.1016/S0169-5002(00)00186-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165401%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference